United Airlines (UAL) shares recently fell 3.47% while the broader market gained, extending a 7.81% monthly decline that underperformed both the S&P 500 and the Transportation sector. The company is anticipated to report a 20.72% year-over-year decline in EPS to $2.64 for its upcoming October 15, 2025, earnings release, despite an expected 2.88% revenue increase to $15.27 billion, with full-year estimates reflecting similar trends. Recent analyst revisions show a slight downward trend in EPS estimates, contributing to UAL's current Zacks Rank #3 (Hold). While trading at a Forward P/E discount to its industry, UAL's PEG ratio suggests a premium relative to its growth prospects compared to the sector average.
United Airlines (UAL) is exhibiting significant weakness relative to the broader market, with its stock declining 3.47% against gains in major indices and underperforming both the S&P 500 and its own Transportation sector over the past month with a 7.81% loss. This bearish sentiment appears to be driven by deteriorating forward-looking fundamentals. For its upcoming earnings release on October 15, 2025, consensus estimates project a steep 20.72% year-over-year decline in EPS to $2.64, a stark contrast to the expected 2.88% increase in revenue to $15.27 billion, indicating significant anticipated margin compression. This trend of rising sales but falling profits extends to the full-year forecast, which projects a 3.12% revenue gain but a 3.39% drop in earnings per share. Underscoring this cautious outlook, the Zacks Consensus EPS estimate has been revised downward by 0.21% in the last 30 days. While UAL trades at a modest discount on a forward P/E basis (9.41 vs. the industry's 10.11), its PEG ratio of 1.25 is substantially higher than the industry average of 0.81, suggesting the stock is unfavorably priced relative to its expected earnings growth.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment